3TC Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Lamivudine

Indications/Uses

In combination w/ other antiretroviral agents for the treatment of HIV-infected adults & childn.

Click to view 3TC detailed prescribing information

Dosage/Direction for Use

Adult & adolescent ≤30 kg 300 mg (two 150-mg tab) once daily or 150 mg twice daily. Childn >3 mth & weighing 21-30 kg ½ tab in the morning & 1 tab in the evening, 14-21 kg ½ tab twice daily.

Click to view 3TC detailed prescribing information

Overdosage

View 3TC overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

Click to view 3TC detailed prescribing information

Special Precautions

Monotherapy treatment, preventive treatment for risk of HIV transmission, moderate to severe renal impairment, pancreatitis, lactic acidosis, hepatomegaly & steatosis, severe immune deficiency. Lactation.

Click to view 3TC detailed prescribing information

Use In Pregnancy & Lactation

Click to view 3TC detailed prescribing information

Adverse Reactions

Hyperlactatemia, headache, nausea, vomiting, upper abdominal pain, diarrhea, rash, alopecia, arthralgia, muscle disorders, fatigue, malaise, fever.

Click to view 3TC detailed prescribing information

Drug Interactions

Trimethoprim/sulphamethoxazole causes an increase in lamivudine plasma level; zalcitabine.

Click to view 3TC detailed prescribing information

Storage

View 3TC storage conditions for details to ensure optimal shelf-life.

Description

View 3TC description for details of the chemical structure and excipients (inactive components).

Action

View 3TC mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antivirals

ATC Classification

J05AF05 - lamivudine ; Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.

Regulatory Classification

Presentation/Packing

Form

3TC tab 150 mg

Packing/Price

60's (Rp436,364/pak)

3TC

lamivudine

Manufacturer:

GlaxoSmithKline Indonesia